drugset / Trial / NCT00665054

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

NCT00665054

Phase 4 Completed 160 enrolled Bayer GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Purpose of the study is:- To assess the efficacy and tolerability of vardenafil in male subjects suffering from erectile dysfunction as compared to placebo- To assess the influence of vardenafil on the self-esteem and self-confidence of subjects suffering from erectile dysfunction following treatment with vardenafil as compared to placebo

Timeline

Start
2004-08
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 5 mg Oral
Subject Vardenafil Small molecule 10 mg Oral
Subject Vardenafil Small molecule 20 mg Oral

Indications